SCHEMBL4334315

SCHEMBL4334315

CC(C)OC(Cc1ccc(CCOC(=O)Nc2cccc(Cl)c2)cc1)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
MAPK1 P28482 3/20 0.55
MAPT P10636 3/20 0.55
TSHR P16473 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
HTT P42858 2/20 0.55
CYP1A2 P05177 2/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
RAB9A P51151 2/20 0.54
NPC1 O15118 1/20 0.54
LMNA P02545 4/20 0.52
HPGD P15428 1/20 0.51
ALOX15 P16050 1/20 0.51
MGLL Q99685 1/20 0.50
PPARG P37231 1/20 0.49
PPARD Q03181 1/20 0.49
PPARA Q07869 1/20 0.49
EPHX2 P34913 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4331720 0.91 MAPK1 (0.52) MEN1KMT2AMAPK1MAPTTSHR
SCHEMBL4333352 0.90 HPGD (0.53) MEN1KMT2AMAPK1MAPTTSHR
SCHEMBL4333102 0.88 NPC1 (0.53) MEN1KMT2ATSHRSMN1; SMN2RAB9A
SCHEMBL4336506 0.87 PPARA (0.48) KMT2ASMN1; SMN2RAB9ANPC1HPGD
SCHEMBL4328950 0.87 MAPT (0.48) MEN1KMT2AMAPK1MAPTTSHR
SCHEMBL4334521 0.86 MEN1 (0.48) MEN1KMT2AMAPK1MAPTTSHR
SCHEMBL4345770 0.84 MAPT (0.47) MEN1KMT2AMAPTSMN1; SMN2HTT
SCHEMBL4338993 0.84 MGLL (0.45) MEN1KMT2AMAPK1MAPTTSHR
SCHEMBL4339117 0.83 MGLL (0.54) MEN1KMT2AMAPK1MAPTTSHR
SCHEMBL4341155 0.82 ALDH1A1 (0.48) MEN1KMT2AMAPK1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 MEN1 4091/4885KMT2A 2774/4885MAPK1 698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.